Direkt zum Inhalt
Merck
  • A reconstituted mammalian APC-kinesin complex selectively transports defined packages of axonal mRNAs.

A reconstituted mammalian APC-kinesin complex selectively transports defined packages of axonal mRNAs.

Science advances (2020-03-24)
Sebastian Baumann, Artem Komissarov, Maria Gili, Verena Ruprecht, Stefan Wieser, Sebastian P Maurer
ZUSAMMENFASSUNG

Through the asymmetric distribution of messenger RNAs (mRNAs), cells spatially regulate gene expression to create cytoplasmic domains with specialized functions. In neurons, mRNA localization is required for essential processes such as cell polarization, migration, and synaptic plasticity underlying long-term memory formation. The essential components driving cytoplasmic mRNA transport in neurons and mammalian cells are not known. We report the first reconstitution of a mammalian mRNA transport system revealing that the tumor suppressor adenomatous polyposis coli (APC) forms stable complexes with the axonally localized β-actin and β2B-tubulin mRNAs, which are linked to a kinesin-2 via the cargo adaptor KAP3. APC activates kinesin-2, and both proteins are sufficient to drive specific transport of defined mRNA packages. Guanine-rich sequences located in 3'UTRs of axonal mRNAs increase transport efficiency and balance the access of different mRNAs to the transport system. Our findings reveal a minimal set of proteins sufficient to transport mammalian mRNAs.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
Natriumphosphat Heptahydrat, ACS reagent, 98.0-102.0%
Sigma-Aldrich
Cobalt(II)-Chlorid Hexahydrat, ACS reagent, 98%
Sigma-Aldrich
DL-Dithiothreitol, ≥98% (HPLC), ≥99.0% (titration)
Sigma-Aldrich
d-Desthiobiotin, ≥98% (TLC)
Sigma-Aldrich
Natriumphosphat, BioReagent, for molecular biology, anhydrous, ≥98%
Sigma-Aldrich
Imidazol, ACS reagent, ≥99% (titration)
Sigma-Aldrich
L-Arginin, reagent grade, ≥98%
Sigma-Aldrich
Kaliumchlorid, BioXtra, ≥99.0%
Sigma-Aldrich
S-Nitroso-N-acetyl-DL-penicillamin, ≥97%, powder